Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.

Arillotta, Davide et al.·Brain sciences·2024·
RPEP-077702024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.
Published In:
Brain sciences, 14(6) (2024)
Database ID:
RPEP-07770

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07770·https://rethinkpeptides.com/research/RPEP-07770

APA

Arillotta, Davide; Floresta, Giuseppe; Papanti Pelletier, G Duccio; Guirguis, Amira; Corkery, John Martin; Martinotti, Giovanni; Schifano, Fabrizio. (2024). Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.. Brain sciences, 14(6). https://doi.org/10.3390/brainsci14060617

MLA

Arillotta, Davide, et al. "Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.." Brain sciences, 2024. https://doi.org/10.3390/brainsci14060617

RethinkPeptides

RethinkPeptides Research Database. "Exploring the Potential Impact of GLP-1 Receptor Agonists on..." RPEP-07770. Retrieved from https://rethinkpeptides.com/research/arillotta-2024-exploring-the-potential-impact

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.